Current Trends in Biotechnology and Pharmacy
Open Access
SCOPUS
  • Year: 2009
  • Volume: 3
  • Issue: 1

Plants as source of novel Anti-Diabetic Drug: Present Scenario and Future Perspectives

  • Author:
  • Soumya Pr. Rout1,, K. A. Chowdary2, D. M. Kar3, Lopamudra Das4
  • Total Page Count: 19
  • Page Number: 37 to 55

1Clinical Operations, AdPharma Inc., Hyderabad-500016, Andhra Pradesh, India

2Dept. of Pharmacology, Roland Institute of Pharmaceutical Sciences, Berhampur, Orissa, India

3Dept. of Pharmacology, Dadhichi College of Pharmacy, Phulnakhara, Cuttack, Orissa, India

4GVK Bio, Hyderabad-500016, Andhra Pradesh, India

*For Correspondence: spr_cology@rediffmail.com

Abstract

For thousands of years plants and their derivatives are being used for treatment of diabetes. Application of modern science to traditional system of medicine has also given birth to compound like Metformin. More than 400 plants incorporated in approximately 700 recipes are used to treat diabetes mellitus in almost two thirds of the world population. A large number of animal studies to test the claimed activity have demonstrated the hypoglycaemic property of many of these plants. In addition, clinical trials have shown some plants as useful antidiabetic agents, but the pure chemical compounds isolated from the crude extracts of these plants do not bear structural resemblance to the antidiabetic drugs in current clinical use nor have they similar mechanisms of action. But still the search for a novel antidiabetic drug advocates the utilization of plants as a potential source and can be achieved by application of modern scientific technology and recent knowledge on the physiological changes in case of Diabetes.

Keywords

Hypoglycaemic, Natural Product, New Chemical Entity, FDA, Toxicity